substance use Archives - Page 2 of 3 - Alliance for Connected Care

Journal of Substance User & Addiction Treatment: Buprenorphine Discontinuation in Telehealth-Only Treatment for Opioid Use Disorder

Journal of Substance User & Addiction Treatment: Buprenorphine Discontinuation in Telehealth-Only Treatment for Opioid Use Disorder At the beginning of the COVID-19 pandemic, federal agencies permitted telehealth initiation of buprenorphine treatment for opioid use disorder (OUD) without in-person assessment. This longitudinal cohort analysis found that a telehealth-only platform reduced risk of buprenorphine discontinuation compared [...]

pbrown2025-04-06T21:14:11-04:00September 25th, 2024|

JAMA Network Open: Stimulant, Antidepressant, and Opioid Telehealth Prescription Trends Between 2019 and 2022

JAMA Network Open: Stimulant, Antidepressant, and Opioid Telehealth Prescription Trends Between 2019 and 2022 This cross-sectional study found that increasing telehealth utilization across medications suggests a growing acceptance, need, or preference for remote services. Opioid prescriptions declined before Q2 of 2020 and continued to decrease by 17.2% from 2019 to 2022. In-person visits accounted [...]

pbrown2025-04-06T20:50:54-04:00September 13th, 2024|

Center for Health Care Strategies: Telehealth and Medications for Opioid Use Disorder: Evidence Roundup

Center for Health Care Strategies: Telehealth and Medications for Opioid Use Disorder: Evidence Roundup In the face of an overwhelming overdose crisis, largely driven by the rise in the synthetic opioid fentanyl, telehealth for MOUD treatment promises to benefit many people. Currently, prescription volumes for MOUD are low and certain under-resourced communities experience significant [...]

pbrown2025-03-05T15:37:17-04:00May 29th, 2024|

Epic Research: ADHD Medications Prescribed at Similar Rates During Telehealth and In-Person Visits

Epic Research: ADHD Medications Prescribed at Similar Rates During Telehealth and In-Person Visits This study analyzed medication prescribing rates for telehealth and office visits, which found that attention deficit hyperactivity disorder (ADHD) medications were prescribed at similar rates during telehealth and in-person visits. Most initial ADHD prescriptions were for stimulant medications in both telehealth (84 [...]

Alliance for Connected Care2023-11-27T18:22:28-04:00June 27th, 2023|

Overall and Telehealth Addiction Treatment Utilization by Age, Race, Ethnicity, and Socioeconomic Status in California After COVID-19 Policy Changes

JAMA Health Forum: Overall and Telehealth Addiction Treatment Utilization by Age, Race, Ethnicity, and Socioeconomic Status in California After COVID-19 Policy Changes This cohort study found that disparities in addiction treatment utilization were not exacerbated following expansion of telehealth during the early phase of the COVID-19 pandemic. Researchers examined whether there were differences [...]

Alliance for Connected Care2023-06-05T15:53:42-04:00May 19th, 2023|

Telehealth for Opioid Use Disorder Retention as a Function of Demographics and Rurality

The American Journal of Drug and Alcohol Abuse: Telehealth for Opioid Use Disorder Retention as a Function of Demographics and Rurality A study published in The American Journal of Drug and Alcohol Abuse found that patients with opioid use disorder (OUD) are significantly more likely to stick with their treatment plan when offered buprenorphine via telemedicine. Patients [...]

Alliance for Connected Care2023-04-25T11:32:10-04:00March 24th, 2023|

Utilization and Satisfaction Remain High Even After Easing of COVID-19 Lockdown Restrictions

Spine Journal: Utilization and Satisfaction Remain High Even After Easing of COVID-19 Lockdown Restrictions This study aimed to define telemedicine utilization rates during and after the initial height of the COVID-19 lockdown period and to determine patient satisfaction with telemedicine during and after the initial height of the COVID-19 lockdown period for spine patients [...]

Alliance for Connected Care2023-04-24T16:15:48-04:00March 1st, 2023|

Adaptation of the Tele-Harm Reduction Intervention to Promote Initiation and Retention in Buprenorphine Treatment Among People Who Inject Drugs

Annuals of Medicine: Adaptation of the Tele-Harm Reduction Intervention to Promote Initiation and Retention in Buprenorphine Treatment Among People Who Inject Drugs The Tele-Harm Reduction (THR) intervention is a multicomponent, telehealth-based and peer-driven intervention to promote HIV viral suppression among people who inject drugs (PWID) accessing a syringe services program (SSP). This study examined buprenorphine initiation [...]

Alliance for Connected Care2023-04-24T16:14:52-04:00March 1st, 2023|

Telehealth Delivery of Behavioral Health Care in Medicaid: Findings from a Survey of State Medicaid Programs

Kaiser Family Foundation: Telehealth Delivery of Behavioral Health Care in Medicaid: Findings from a Survey of State Medicaid Programs Kaiser Family Foundation (KFF) surveyed state Medicaid officials about policies and trends related to telehealth delivery of behavioral health services. The survey found that states most commonly reported adding audio-only telehealth coverage of behavioral [...]

Alliance for Connected Care2023-01-24T17:50:21-04:00January 10th, 2023|

CareConnect: Adapting a Virtual Urgent Care Model to Provide Buprenorphine Transitional Care

NEJM Catalyst: CareConnect: Adapting a Virtual Urgent Care Model to Provide Buprenorphine Transitional Care Medications for opioid use disorder (OUD) such as buprenorphine are the gold standard for treatment of OUD, but patients face many barriers accessing these medications. To address this gap, a team at Penn Medicine created CareConnect, which leveraged new [...]

Alliance for Connected Care2023-01-24T12:00:25-04:00November 16th, 2022|

Thank you for signing up!